Intellia Therapeutics (NTLA) Q1 2023 Earnings

4MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-1.49
-1.38
-1.28
-1.17

Details

Expected EPS
-1.4
Actual EPS
-1.17
Surprise EPS
0.23
Surprise Percent
+16.43%

Description

Intellia Therapeutics (NTLA) has reported earnings of -1.17 per share for Q1 2023.

0 Comments

Share your thoughts